These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15947369)

  • 1. The value of clopidogrel administered postoperatively following a non-ST-segment elevation acute coronary syndrome.
    Gluckman TJ; Rade JJ; Schulman SP
    Chest; 2005 Jun; 127(6):2297. PubMed ID: 15947369
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Stein PD; Schünemann HJ; Dalen JE; Gutterman D
    Chest; 2004 Sep; 126(3 Suppl):600S-608S. PubMed ID: 15383486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pexelizumab in ischemic heart disease: a systematic review and meta-analysis on 15,196 patients.
    Testa L; Van Gaal WJ; Bhindi R; Biondi-Zoccai GG; Abbate A; Agostoni P; Porto I; Andreotti F; Crea F; Banning AP
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):884-93. PubMed ID: 18954626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy.
    Mehta SR; Bassand JP; Chrolavicius S; Diaz R; Fox KA; Granger CB; Jolly S; Rupprecht HJ; Widimsky P; Yusuf S;
    Am Heart J; 2008 Dec; 156(6):1080-1088.e1. PubMed ID: 19033002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial comparing clopidogrel versus ticlopidine therapy in patients undergoing infarct artery stenting for acute myocardial infarction with abciximab as adjunctive therapy.
    Parodi G; Sciagrà R; Migliorini A; Memisha G; Moschi G; Valenti R; Pupi A; Antoniucci D
    Am Heart J; 2005 Aug; 150(2):220. PubMed ID: 16086921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does combined clopidogrel and statin therapy benefit patients with non-ST-elevation myocardial infarction?
    Altman R
    Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):558-9. PubMed ID: 16258563
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic value of a high on-clopidogrel treatment platelet reactivity in bivalirudin versus abciximab treated non-ST-segment elevation myocardial infarction patients. ISAR-REACT 4 (Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment-4) platelet substudy.
    Sibbing D; Bernlochner I; Schulz S; Massberg S; Schömig A; Mehilli J; Kastrati A
    J Am Coll Cardiol; 2012 Jul; 60(5):369-77. PubMed ID: 22682553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.
    Sabatine MS; Cannon CP; Gibson CM; López-Sendón JL; Montalescot G; Theroux P; Claeys MJ; Cools F; Hill KA; Skene AM; McCabe CH; Braunwald E;
    N Engl J Med; 2005 Mar; 352(12):1179-89. PubMed ID: 15758000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet therapy in percutaneous coronary intervention: integration of prasugrel into clinical practice.
    Thomas D; Giugliano RP
    Crit Pathw Cardiol; 2009 Mar; 8(1):12-9. PubMed ID: 19258833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extent of ST-segment resolution after fibrinolysis adds improved risk stratification to clinical risk score for ST-segment elevation myocardial infarction.
    Harkness JR; Sabatine MS; Braunwald E; Morrow DA; Sloan S; Wiviott SD; Giugliano RP; Antman EM; Cannon CP; Scirica BM
    Am Heart J; 2010 Jan; 159(1):55-62. PubMed ID: 20102867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Harrington RA; Becker RC; Ezekowitz M; Meade TW; O'Connor CM; Vorchheimer DA; Guyatt GH
    Chest; 2004 Sep; 126(3 Suppl):513S-548S. PubMed ID: 15383483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
    Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
    JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention: Results of a Nonrandomized Observational Study.
    Räber L; Klingenberg R; Heg D; Kelbæk H; Roffi M; Tüller D; Baumbach A; Zanchin T; Carballo D; Ostojic M; Stefanini GG; Rodondi N; von Birgelen C; Moschovitis A; Engstrøm T; Gencer B; Auer R; Meier B; Mach F; Lüscher TF; Jüni P; Matter CM; Windecker S;
    JACC Cardiovasc Interv; 2015 Jul; 8(8):1064-1074. PubMed ID: 26205445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of P2Y12 receptor inhibition in patients with ST-segment elevation myocardial infarction.
    Alexopoulos D; Xanthopoulou I; Goudevenos J
    Am J Cardiol; 2014 Jun; 113(12):2064-9. PubMed ID: 24793666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits and risks of using clopidogrel before coronary artery bypass surgery: systematic review and meta-analysis of randomized trials and observational studies.
    Biancari F; Airaksinen KE; Lip GY
    J Thorac Cardiovasc Surg; 2012 Mar; 143(3):665-675.e4. PubMed ID: 21703636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.
    Gibson CM; Murphy SA; Pride YB; Kirtane AJ; Aroesty JM; Stein EB; Ciaglo LN; Southard MC; Sabatine MS; Cannon CP; Braunwald E;
    Am Heart J; 2008 Jan; 155(1):133-9. PubMed ID: 18082504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of clopidogrel use on mortality and major bleeding in patients undergoing coronary artery bypass surgery.
    Nesher N; Singh SK; Fawzy HF; Sever JY; Goldman BE; Cohen GN; Laflamme C; Fremes SE
    Interact Cardiovasc Thorac Surg; 2010 May; 10(5):732-6. PubMed ID: 20061339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin and clopidogrel in patients with ACS undergoing PCI: CURE and PCI-CURE.
    Mehta SR
    J Invasive Cardiol; 2003 Mar; 15 Suppl B():17B-20B; discussion 20B-21B. PubMed ID: 12724582
    [No Abstract]   [Full Text] [Related]  

  • 19. The FDA prasugrel review: adjudication of myocardial infarction controversy.
    Serebruany VL
    Cardiology; 2009; 114(2):126-9. PubMed ID: 19506374
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of pretreatment with clopidogrel on initial patency and outcome in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review.
    Vlaar PJ; Svilaas T; Damman K; de Smet BJ; Tijssen JG; Hillege HL; Zijlstra F
    Circulation; 2008 Oct; 118(18):1828-36. PubMed ID: 18852370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.